Skip to menu Skip to content Skip to footer

2025

Journal Article

Tolerability and effectiveness of face-masks in reducing cough aerosols for children with cystic fibrosis

Tay, George T.P., Smith, Kim, He, Congrong, Ballard, Emma L., Wood, Michelle E., Stockwell, Rebecca E., Morawska, Lidia, Wainwright, Claire E. and Bell, Scott C. (2025). Tolerability and effectiveness of face-masks in reducing cough aerosols for children with cystic fibrosis. Journal of Cystic Fibrosis. doi: 10.1016/j.jcf.2025.01.008

Tolerability and effectiveness of face-masks in reducing cough aerosols for children with cystic fibrosis

2024

Journal Article

Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes

Madden, Danielle E., Baird, Timothy, Bell, Scott C., McCarthy, Kate L., Price, Erin P. and Sarovich, Derek S. (2024). Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes. Genome Medicine, 16 (1) 78. doi: 10.1186/s13073-024-01346-z

Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes

2024

Journal Article

Practical guidance for clinical microbiology laboratories: updated guidance for processing respiratory tract samples from people with cystic fibrosis

Saiman, Lisa, Waters, Valerie, Lipuma, John J., Hoffman, Lucas R., Alby, Kevin, Zhang, Sean X., Yau, Yvonne C., Downey, Damian G., Sermet-Gaudelus, Isabelle, Bouchara, Jean-Philippe, Kidd, Timothy J., Bell, Scott C. and Brown, A. Whitney (2024). Practical guidance for clinical microbiology laboratories: updated guidance for processing respiratory tract samples from people with cystic fibrosis. Clinical Microbiology Reviews, 37 (3), e0021521. doi: 10.1128/cmr.00215-21

Practical guidance for clinical microbiology laboratories: updated guidance for processing respiratory tract samples from people with cystic fibrosis

2024

Conference Publication

Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study

Duplancic, Christine, Wainwright, Claire, Thomson, Rachel, Rogers, Geraint, Clements, Archie, Floto, Andre and Bell, Scott (2024). Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons.

Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study

2024

Conference Publication

Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trial

Rice, Megan, Hicks, Daniel, Jong, Tiffany, Gailer, Nicolas, Joshi, Sri, Stevens, Luke, Lee, Kate, Thomson, Rachel, Burke, Andrew, Grimwood, Keith, Bell, Scott, Clark, Julia and Wainwright, Claire E. (2024). Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trial. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons.

Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trial

2024

Conference Publication

Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT)

Hicks, D., Jong, T., Rice, M., Gailer, N., Joshi, S., Stevens, L., Lee, K., Thomson, R., Burke, A., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2024). Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT). 47th European Cystic Fibrosis Conference, Glasgow, United Kingdom, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(24)00244-3

Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT)

2024

Journal Article

Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis

Blake, Tamara L., Sly, Peter D., Andersen, Isabella, Wainwright, Claire E., Reid, David W., Bell, Scott C., Smith, Briana R., Kettle, Anthony J. and Dickerhof, Nina (2024). Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis. Journal of Cystic Fibrosis, 23 (6), 1163-1166. doi: 10.1016/j.jcf.2024.04.009

Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis

2024

Conference Publication

Mycobacteria acquisition from potable water

Ramsay, K., Smith, K., Carter, R., Clayton, M., Thomson, R. and Bell, S. (2024). Mycobacteria acquisition from potable water. TSANZSRS 2024 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science,, Gold Coast, QLD, Australia, 22-26 March 2024. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/resp.14673

Mycobacteria acquisition from potable water

2024

Journal Article

Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis

Tarique, Abdullah A., Tuladhar, Neeraj, Kelk, Dean, Begum, Nelufa, Lucas, Richard M., Luo, Lin, Stow, Jennifer L., Wainwright, Claire E., Bell, Scott C., Sly, Peter D. and Fantino, Emmanuelle (2024). Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis. Cells, 13 (2) 166, 1-13. doi: 10.3390/cells13020166

Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis

2024

Journal Article

Standards for the care of people with cystic fibrosis; establishing and maintaining health

Southern, Kevin, Addy, Charlotte, Bell, Scott C., Bevan, Amanda, Borawska, Urzula, Brown, Catherine, Burgel, Pierre-Régis, Button, Brenda, Castellani, Carlo, Chansard, Audrey, Chilvers, Mark, Davies, Gwyneth, Davies, Jane, De Boeck, Kris, Declercq, Dimitri, Doumit, Michael, Drevinek, Pavel, Fajac, Isabelle, Gartner, Silvia, Georgiopoulos, Anna, Gursli, Sandra, Gramegna, Andrea, Hansen, Carina M. E., Hug, Martin, Lammertyn, Elise, Landau, Edwina (Eddie) C., Langley, Ross, Mayer-Hamblett, Nicole, Middleton, Anna ... van Koningsbruggen-Rietschel, Silke (2024). Standards for the care of people with cystic fibrosis; establishing and maintaining health. Journal of Cystic Fibrosis, 23 (1), 12-28. doi: 10.1016/j.jcf.2023.12.002

Standards for the care of people with cystic fibrosis; establishing and maintaining health

2024

Book Chapter

Working with cystic fibrosis

Bell, Scott C., Sufian, Beth S. and Passamano, James A. (2024). Working with cystic fibrosis. Hodson and Geddes’ Cystic Fibrosis. (pp. 465-476) edited by Andrew Bush, Margarida D. Amaral, Jane C. Davies, Nicholas J. Simmonds, Jennifer L. Taylor-Cousar and Sarath C. Ranganathan. Boca Raton, FL, United States: CRC Press. doi: 10.1201/9781003262763-44

Working with cystic fibrosis

2023

Journal Article

Letter to the editor

Kumar, Shanal and Bell, Scott (2023). Letter to the editor. Bone, 177 116890, 1-2. doi: 10.1016/j.bone.2023.116890

Letter to the editor

2023

Journal Article

Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens

Huang, Casey K., Weerasekara, Anjani, Lu, Ji, Carter, Robyn, Weynberg, Karen D., Thomson, Rachel, Bell, Scott and Guo, Jianhua (2023). Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens. Water Research: X, 21 100201, 100201. doi: 10.1016/j.wroa.2023.100201

Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens

2023

Journal Article

Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease

Baird, Timothy and Bell, Scott (2023). Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease. Clinics in Chest Medicine, 44 (4), 847-860. doi: 10.1016/j.ccm.2023.06.008

Cystic fibrosis-related nontuberculous mycobacterial pulmonary disease

2023

Journal Article

Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas

Evans, Ieuan E. S., Kumar, Shanal, France, Megan, Smith, Daniel, Masel, Philip, Tay, George, Henderson, Daniel, Bell, Scott C. and Reid, David (2023). Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas. Respirology Case Reports, 11 (12) e01235, 1-4. doi: 10.1002/rcr2.1235

Paraquat ingestion in an adult with cystic fibrosis (CF): Diagnostic and management dilemmas

2023

Journal Article

In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates

Burke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938

In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates

2023

Journal Article

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

Mayer-Hamblett, Nicole, Clancy, John Paul, Jain, Raksha, Donaldson, Scott H., Fajac, Isabelle, Goss, Christopher H., Polineni, Deepika, Ratjen, Felix, Quon, Bradley S., Zemanick, Edith T., Bell, Scott C., Davies, Jane C., Jain, Manu, Konstan, Michael W., Kerper, Natanya R., LaRosa, Tré, Mall, Marcus A., McKone, Edward, Pearson, Kelsie, Pilewski, Joseph M., Quittell, Lynne, Rayment, Jonathan H., Rowe, Steven M., Taylor-Cousar, Jennifer L., Retsch-Bogart, George and Downey, Damian G. (2023). Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective. The Lancet Respiratory Medicine, 11 (10), 932-944. doi: 10.1016/s2213-2600(23)00297-7

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

2023

Journal Article

A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis

Ryan, Harrigan, Ballard, Emma, Stockwell, Rebecca E., Duplancic, Christine, Thomson, Rachel M., Smith, Kimberley and Bell, Scott C. (2023). A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis. BMC Pulmonary Medicine, 23 (1) 323, 1-10. doi: 10.1186/s12890-023-02611-4

A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis

2023

Journal Article

Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex

Ramsay, Kay A., Rehman, Attika, Wardell, Samuel T., Martin, Lois W., Bell, Scott C., Patrick, Wayne M., Winstanley, Craig and Lamont, Iain L. (2023). Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex. PLoS One, 18 (5) e0285856, 1-14. doi: 10.1371/journal.pone.0285856

Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex

2023

Conference Publication

In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates

Burke, A. J., Carter, R., Tolson, C., Congdon, J., Duplancic, C., Bursle, E., Bell, S., Roberts, J. and Thomson, R. (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates. ATS 2023 International Conference, Washington, DC USA, 19-24 May 2023. Washington, DC USA: American Thoracic Society. doi: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2968

In vitro susceptibility testing of imipenem- relebactam and tedizolid against australian mycobacterium abscessus isolates